We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.88B
AUM Growth
+$38.2M
(+0.65%)
Cap. Flow
-$157M
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
14.28%
Holding
999
New
192
Increased
183
Reduced
371
Closed
222
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$48.5M |
| 2 |
Intel
INTC
|
+$44.3M |
| 3 |
Southwest Airlines
LUV
|
+$38.2M |
| 4 |
Cencora
COR
|
+$37.7M |
| 5 |
Starbucks
SBUX
|
+$35.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$45.8M |
| 2 |
Palo Alto Networks
PANW
|
+$39.7M |
| 3 |
EOG Resources
EOG
|
+$34.1M |
| 4 |
Verizon
VZ
|
+$33.5M |
| 5 |
Advance Auto Parts
AAP
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.74% |
| 2 | Healthcare | 16.87% |
| 3 | Financials | 15.6% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
701
DELISTED
Array Biopharma Inc
ARRY
| $203K | ﹤0.01% |
+27,500
| New | +$196K |
|
|
MERU
702
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $202K | ﹤0.01% |
140,274
+45,700
| +48% | +$119K |
|
|
UMPQ
703
DELISTED
Umpqua Holdings Corp
UMPQ
| $199K | ﹤0.01% |
11,590
| – | – |
|
|
SMRT
704
DELISTED
Stein Mart Inc
SMRT
| $198K | ﹤0.01% |
15,904
+2,700
| +20% | +$38.2K |
|
|
TE
705
DELISTED
TECO ENERGY INC
TE
| $196K | ﹤0.01% |
10,080
-185,051
| -95% | -$3.74M |
|
|
INWK
706
DELISTED
InnerWorkings, Inc.
INWK
| $195K | ﹤0.01% |
29,004
-115,424
| -80% | -$724K |
|
707
KRONOS Worldwide
KRO
$761M
| $191K | ﹤0.01% |
15,100
-19,505
| -56% | -$237K |
|
|
AVEO
708
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $190K | ﹤0.01% |
13,082
+4,502
| +52% | +$49.2K |
|
709
Supernus Pharmaceuticals
SUPN
$2.68B
| $189K | ﹤0.01% |
+15,600
| New | +$147K |
|
|
IRG
710
DELISTED
Ignite Restaurant Group, Inc.
IRG
| $189K | ﹤0.01% |
39,000
-15,722
| -29% | -$107K |
|
|
DZSI
711
DELISTED
DZS Inc. Common Stock
DZSI
| $188K | ﹤0.01% |
28,885
-5,140
| -15% | -$36.5K |
|
|
PPIH
712
Perma-Pipe International
PPIH
$204M
| $185K | ﹤0.01% |
29,532
-8,700
| -23% | -$54.2K |
|
|
ANTH
713
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $181K | ﹤0.01% |
5,063
-787
| -13% | -$23.3K |
|
|
IMUC
714
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $178K | ﹤0.01% |
9,152
+1,303
| +17% | +$32.7K |
|
|
EGIO
715
DELISTED
Edgio, Inc. Common Stock
EGIO
| $174K | ﹤0.01% |
1,197
-418
| -26% | -$52.9K |
|
|
GLUU
716
DELISTED
Glu Mobile Inc.
GLUU
| $172K | ﹤0.01% |
34,300
| – | – |
|
717
FNB Corp
FNB
$6.78B
| $170K | ﹤0.01% |
12,900
-28,800
| -69% | -$367K |
|
718
Stereotaxis
STXS
$129M
| $170K | ﹤0.01% |
103,521
-118,762
| -53% | -$189K |
|
|
ISLE
719
DELISTED
Isle of Capri Casinos Inc
ISLE
| $170K | ﹤0.01% |
12,096
-26,200
| -68% | -$301K |
|
720
Madrigal Pharmaceuticals
MDGL
$12.6B
| $168K | ﹤0.01% |
2,471
-12,417
| -83% | -$1.06M |
|
721
Pacific Biosciences
PACB
$422M
| $163K | ﹤0.01% |
27,900
-46,394
| -62% | -$320K |
|
722
Universal Technical Institute
UTI
$2.08B
| $159K | ﹤0.01% |
16,600
-19,018
| -53% | -$177K |
|
|
DTLK
723
DELISTED
Datalink Corp
DTLK
| $157K | ﹤0.01% |
+13,006
| New | +$156K |
|
|
ALSK
724
DELISTED
Alaska Communications Systems
ALSK
| $149K | ﹤0.01% |
88,867
-72,735
| -45% | -$123K |
|
|
BCOV
725
DELISTED
Brightcove, Inc.
BCOV
| $147K | ﹤0.01% |
+20,000
| New | +$155K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2015 Portfolio in Review
As of Q1 2015, Jacobs Levy Equity Management held 999 positions worth $5.88B, up 0.65% from $5.84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management's Q1 2015 filing shows 192 new, 183 increased, 371 reduced and 222 closed positions. Its largest new stake was Starbucks: 791,940 shares worth $37.5M. The largest sale was IBM, an estimated $45.8M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q1 2015 buy was Starbucks: 791,940 shares worth $37.5M.
- Jacobs Levy Equity Management added most to AbbVie in Q1 2015, an estimated $48.5M increase.
- Jacobs Levy Equity Management's biggest Q1 2015 reduction was IBM, cutting an estimated $45.8M.
- Jacobs Levy Equity Management fully exited Charles Schwab in Q1 2015, selling an estimated $27.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.88B portfolio in Q1 2015.
- Jacobs Levy Equity Management opened 192 new positions and closed 222 in Q1 2015.
- Jacobs Levy Equity Management's portfolio value rose 0.65% quarter-over-quarter to $5.88B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2015, filed 15 May 2015.